Fake Ozempic Seized by FDA as Demand for Obesity Drugs Soars (1)

The US Food and Drug Administration has seized thousands of units of counterfeit Ozempic, Novo Nordisk A/S’s diabetes drug that’s been adapted into a blockbuster weight-loss treatment, and warned against using them.

The regulator advised wholesalers, retail pharmacies, health care practitioners and patients to check the product they have received and not distribute or sell products labeled with lot number NAR0074 and serial number 430834149057.

The FDA and Novo are testing the seized products and don’t yet have information about the drugs’ identity, quality, or safety.

Images released by the FDA of authentic and counterfeit Ozempic needles.

Source: FDA

Demand for Ozempic has soared as people turn to a new range ...